B. 1981.Glomerular basement membrane and anti-GBM antibody disease. Nephron 9:205-208.Kirschbaum BB. Glomerular basement membrane and anti-GBM antibody disease. Nephron 1981; 29 (5-6): 205-8.Kirschbaum B.B. (1981). Glomerular basement membrane and anti-GBM antibody disease (Review). Nephron...
Dekervel, M., Fage, N., Vinatier, E.et al.Anti-GBM disease fueled by cardiopulmonary bypass, a lesson for the clinical nephrologist.J Nephrol38, 777–780 (2025). https://doi.org/10.1007/s40620-024-02131-2 Download citation Received27 June 2024 ...
“In anti-GBM disease, timely treatment is key to minimizing its potential damage to the kidneys. However, the ultra-rare nature of this condition can delay its identification and diagnosis. Imlifidase, not only reduces antibody lev...
Antiglomerular basement membrane antibody-mediated nephritis. In: Schrier RW, Gottschalk CW, editors. Disease of the kidney. Boston: Little Brown; 1988. p. 2091–126. O’Donoghue DJ, Short CD, Brenchley PE, Lawler W, Ballardie FW. Sequential development of systemic vasculitis with anti-...
AAV, anti-neutrophil cytoplasm antibody–associated vasculitis; DP, double positive; GBM, anti-glomerular basement membrane disease. Unadjusted predictors of death included RRT at presentation (hazard ratio [HR]: 2.2 [1.63–2.97]; P < 0.01), lung hemorrhage (HR: 1.45 [1.06–1.99]; P = 0.02)...
Results Circulating IgG autoantibodies binding to laminin-521 were found in about one third of patients with anti-GBM antibody GN, but were not detected in healthy controls or in patients with other glomerular diseases. Autoreactivity toward laminin-521 was significantly more common in patients with...
Figure 6. Glucocorticoid administration at least partially ameliorated cell proliferation and proteinuria in anti-GBM antibody-induced proliferative GN via the induction of p21CIP1. Wistar-Kyoto rats were divided into three groups: the control group, the anti-GBM GN without prednisolone group, and the...
These data suggest that increased expression of HB-EGF and erbB4/HER4 is a response to inflammation in the glomerulus in accelerated anti-GBM disease. to determine the potential role of HB-EGF in anti-GBM disease, a blocking monoclonal antibody against HB-EGF (DE10) was administered by ...
Glomerulonephritis due to antineutrophil cytoplasm antibody-associated vasculitis: an update on approaches to management. Nephrology (Carlton) 2005;10:368–376. 3. Holdsworth SR, Neale TJ, Wilson CB. Abrogation of macrophage- dependent injury in experimental glomerulonephritis in the rabbit. Use of an...
Levy JB, Turner AN, Rees AJ et al (2001) Long- term outcome of anti-glomerular basement membrane antibody disease treated with plasma Die Nephrologie 5 · 2023 303 Hier steht eine Anzeige. K Hier steht eine Anzeige. K exchange and immunosuppression. Ann Intern Med 134:1033–1042 16. Mc...